UCSF

Topics and Expertise: Optivia Biotechnology

Drug safety is the aim of UCSF-Optivia research partnership

Pharmacogenetics expert Kathy Giacomini, PhD, co-chair of the UCSF Department of Bioengineering and Therapeutic Sciences, is leading the UCSF arm of a research partnership in which her team will profile 2,000 prescri